Global Cytomegalovirus Retinitis Market Size, Share | MarketResearchReports.biz
Latest
industry research report on: Global Cytomegalovirus Retinitis Market
: Industry Size, Share, Research, Reviews, Analysis, Strategies,
Demand, Growth, Segmentation, Parameters, Forecasts
Cytomegalovirus
(CMV) Retinitis
is caused by cytomegalovirus infection, which is a herpes-type virus
that affects the retina of the human eye among patients having a weak
immune system that could be due to conditions such as AIDS, leukemia
and/or pregnancy. Symptomatic conditions include floaters, flashes,
and blind spots besides loss of peripheral or blurred vision in the
eyes of immune compromised patients.CMV infection often leads to
hemorrhagic retinal inflammation along with vascular distribution.
The CMV infection if left untreated spreads from one eye to the
other, eventually leading to visual loss and/or complete blindness.
Therefore, prompt diagnosis through blood as well as urine tests
besides other optical tests that involve withdrawal of a small
specimen fluid from the infected eye is recommended.
Global CMV retinitis market can
be segmented on the basis of anti-CMV drugs or anti-infective
ophthalmic drugs into Foscarnet, Ganciclovir, Cidofovir, Fomivirsen
and others. In the anti-CMV drugs segment, various off-label drugs
are also being used, however many of these drugs have serious
contraindications. In this market segment, one of the key challenges
is drug resistance which needs to be counterfeited with clinical
trials and pipeline drugs. For instance, intraocular Fomivirsen has
been found to prevent CMV retinitis during clinical trials. Further,
the CMV retinitis market can also be segmented on the basis of
available therapeutic treatments into anti-CMV Oral Ganciclovir,
anti-CMV Intravenous drug therapy, anti-CMV Intraocular (local), and
anti-HIV Systemic and Retinal Detachment through Vitrectomy. Oral
therapy is relatively more convenient and recommended for peripheral
retinitis cases but not for later stages of CMV retinitis when the
condition becomes visually threatening.
Intravenous
therapy treats the infection along with protecting the eye against
systemic infection. Furthermore, higher longevity has been observed
with Foscarnet in comparison to Ganciclovir. Intraocular therapy is
highly effective in controlling infection, and is relatively less
costly than systemic and superior to intravenous. However,
intraocular implants need replacement after a duration of 6-8 months,
especially among those having lower levels of T-helper cell counts.
Systemic treatment is directed towards the HIV virus through a
combination of reverse transcriptase and protease inhibitors, which
is a highly active anti-retroviral therapy to restore immune system
besides raising the T-helper cell counts.
Geographically,
North America (U.S and Canada) dominate the CMV Retinitis market
followed by Europe as leading manufacturers of CMV Retinitis are
domiciled in these regions having majority of their operations in the
local regional markets. However, Asia Pacific, Africa as well as
Latin America would also prove to be the highly profitable markets in
the future due to the high prevalence rates for immunodeficiency
diseases in these regions.
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1351265
Taking into consideration the
staggering figures of around 33,400,000 persons living with HIV
infection, who are highly susceptible to the CMV retinitis condition
globally, this specialized and niche market is estimated to escalate
at a high pace. However, some of the restraints in this foresighted
growth would include the newer anti-HIV medications, which prevent
occurrence of this disease. Moreover, since this disease is largely
concentrated to patients with pre-existing conditions such as HIV the
overall size of the market will be smaller as CMV retinitis occur in
approximately 46% of the HIV patients in comparison with other common
diseases.
Some of the major players that
are currently operating in this market include Bausch & Lomb
Incorporated, CSL Behring, Emcure Pharms, Ltd., Endo Pharmaceuticals,
Inc., F. Hoffmann-La Roche Ltd., Hospira, Inc., Luitpold
Pharmaceuticals, Inc., Mylan N.V., and Valeant Pharmaceuticals
International, Inc. among others.
This research report analyzes
this market on the basis of its market segments, major geographies,
and current market trends. Geographies analyzed under this research
report include
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
This report provides
comprehensive analysis of
Market growth drivers
Factors limiting market
growth
Current market trends
Market structure
Market projections for
upcoming years
This report is a complete study
of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It
includes analysis of recent developments in technology, Porter’s
five force model analysis and detailed profiles of top industry
players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with
detailed value chain analysis.
Reasons for Buying this
Report
This report provides
pin-point analysis for changing competitive dynamics
It provides a forward
looking perspective on different factors driving or restraining
market growth
It provides a six-year
forecast assessed on the basis of how the market is predicted to grow
It helps in understanding
the key product segments and their future
It provides pin point
analysis of changing competition dynamics and keeps you ahead of
competitors
It helps in making informed
business decisions by having complete insights of market and by
making in-depth analysis of market segments
It provides distinctive
graphics and exemplified SWOT analysis of major market segments
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment